Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions

Oral Oncology

Volumn 35, Issue 2, 1999, Pages 180-186

  Krȩcicki, Tomasz ^a,b   Jeleń, Michał ^a   Zalesska Krȩcicka, Maria ^a   Rak, Jerzy ^a   Szkudlarek, Teresa ^a   Jeleń Krzeszewska, Joanna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b NONE   (Poland)

Author keywords

EGFR; Ki 67; Laryngeal lesions; PCNA

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM DYSPLASIA; EPITHELIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LARYNX MUCOSA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPIDERMAL GROWTH FACTOR; STAINING AND LABELING;

EID: 18244410955     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00100-6     Document Type: Article

References (33)

1. Bień S, Meder J, Rak K. Zasady postȩpowania onkologicznego w praktyce ogólnolekarskiej. Warszaw: Centrum Onkologii -Instytut im. Marii Skłodowskiej-Curie, 1991.
2. Kearsley JH, Leonard JH, Walsh MD, Wright GR. A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas. Pathology 1991;23:189-94.
3. Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994;54:3153-9.
4. Weber RS, Pathak S, Frankenthaler R, Gallick GE, Sacks PG. Effect of epidermal growth factor (EGF) on a newly established head and neck squamous-carcinoma cell line. Otolaryngol Head Neck Surg 1992;10:529-35.
5. Jonathan C, Irish JC, Bernstein A. Oncogens in head and neck cancer. Laryngoscope 1993;103:42-52.
6. Miyaguchi M, Olofsson J, Hellquist HB. Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma. Acta Otolaryngol (Stockh) 1990;110:309-13.
7. Kissane JM. Anderson's pathology. St. Louis: The C.V. Mosby Company, 1985.
8. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
9. Verhuijen R, Kuipers HJH, Schlingemann RO. Ki67 detects a nuclear matrix-associated proliferation-related antigen. Intracellular localisation during interphase. J Cell Science 1989a;92:123-5.
10. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990;17:489-503.
11. Bernard NJ, Hall PA, Lemoine NR, Kadar N. Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J Pathol 1987;152:287-95.
12. Hall PA, Richards MA, Gregory WM, D'Ardenne AJ, Lister TA, Stansfield AG. The prognostic significance of Ki67 immunostaining in non-Hodgkins lymphoma. J Pathol 1988;71:1157-60.
13. Miyachi K, Fritzler MJ, Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978;121:2228-34.
14. Bravo R, Frank R, Blindell PA, MacDonald-Bravo H. Cyclin/ PCNA is the auxiliary protein to DNA polymerase-delta. Nature 1987;326:515-20.
15. Takasaki Y, Deng JS, Tan EM. A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 1981;154:1899-909.
16. Celis JE, Madsen P, Nielsen S, Celis A. Nuclear patterns of cyclin (PCNA) antigen distribution subdivide S-phase in cultured cells-some applications of PCNA antibodies. Leuk Res 1986;10: 237-49.
17. Golusiński W, Szmeja Z, Olofsson J, Biczysko W, Krygier-Stojanowska A, Majewski P. Wartość diagnostyczna i prognostyczna onkogenu p53 wybranych markerów nowotworowych (Ki67, PCNA, DNA ploidii) ultrastruktury u chorych na raka krtani. Otolaryngol Pol 1996;50:607-17.
18. Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 1995;104:503-10.
19. Skopelitou A, Korkolopoulou P, Papanikolau A, Hadjiyannakis M. Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma. J Cancer Res Clinl Oncol 1993;119:379-81.
20. Störkel S, Reichert T, Reiffen KA, Wagner W. EGFR and PCNA expression in oral squamous cell carcinomas - a valuable tool in estimating the patient's prognosis. Oral Oncol, Eur J Cancer Vol 1993;29B:273-7.
21. Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O, Demard F. Characterization, quantification, and potential clinical value of epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 1991; 13:132-9.
22. Miyaguchi M, Sakai S, Olofsson J, Kuwabara H, Sakamoto H. Prognostic significance of epidermal growth factor receptor in squamous cell carcinoma of the maxillary sinus. Eur Arch Otorhinolaryngol 1993;249:478-81.
23. Maurizi M, Scambia G, Panici BP, Ferrandina G, Almadori G, Paludetti G, De Vincenzo R, Distefano M, Brinchi D, Cadoni G, Manusco S. EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance. Int J Cancer 1992;52:862-6.
24. Uhlman DL, Adams G, Knapp D, Aeppli M, Niehans G. Immunohistochemical staining for markers of future neoplastic progression in the larynx. Cancer Res 1996;56:2199-205.
25. Scambia G, Benedetti Panici P, Battaglia F, Ferrandina G, Almadori G, Paludetti G, Maurizi M, Mancuso S. Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors. Cancer 1991:67;1347-51.
26. Grandis JR, Melhem MF, Barnes EL, Tweardy DJ. Quantitative immunohistochemical analysis of transforming growth factor - alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 1996;78:1284-92.
27. Zidar N, Gale N, Cor A, Kambic V. Expression of Ki-67 antigen and proliferative cell nuclear nuclear antigen in benign and malignant epithelial lesions of the larynx. J Laryngol Otol 110;1996:440-5.
28. Kearsley JH, Furlong KL, Cooke RA, Walters MJ. An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br J Cancer 1990;61:821-7.
29. Shin DV, Voravud N, Ro JY, Lee JS, Hong WK, Hittelman WN. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J Nat Cancer Inst 1993;85:971-8.
30. Coltera MD, Zarbo RJ, Sakr WA, Gown AM. Markers of dysplasia of the upper aerodigestive tract. Am J Pathol 199;141:817-25.
31. Lam K, Law S, So M, Ma L, Wong J. Prognostic implication of proliferative markers MIB-1 and PC10 in oesophageal squamous cell carcinoma. Cancer 1996;77:7-13.
32. Lorz M, Meyer-Breiting E, Bettinger R. Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer. Eur Arch Otorhinol 1994;251:91-4.
33. Wen QH, Nashimura T, Miwa T, Nagayama I, Furukawa M. Expression of EGE, EGFR and PCNA in laryngeal lesions. J Laryngol Otol 1995;109:630-6.